Showing 481-490 of 20873 results for "".
- Spatial Multi-Omics Reveals Metformin's Region-Specific Renal Protective Effects in Diabeteshttps://reachmd.com/news/spatial-multi-omics-reveals-metformins-region-specific-renal-protective-effects-in-diabetes/2475820/At the intersection of glycemic control and renal preservation, endocrinologists and nephrologists face a pressing dilemma in type 2 diabetes management: how to harness metformin’s established glucose-lowering effects while optimizing its nuanced, region-specific contributions to kidney pro
- New Blood Test Could be an Early Warning for Diabetes in Childrenhttps://reachmd.com/news/new-blood-test-could-be-an-early-warning-for-diabetes-in-children/2468278/Credit: Pixabay/CC0 Public Domain A new type of blood test using lipids could make it easier to identify children at risk of
- Understanding the Risk Factors for Diabetic Retinopathy in Adults and the Elderlyhttps://reachmd.com/news/understanding-the-risk-factors-for-diabetic-retinopathy-in-adults-and-the-elderly/2484269/A new institution-based case-control analysis of adults and older patients with diabetes found that the presence of systemic complications conferred an adjusted ~3.6-fold inc
- Cardioprotective Strategies in Diabetes Management: Broadening Horizonshttps://reachmd.com/news/cardioprotective-strategies-in-diabetes-management-broadening-horizons/2482989/The use of SGLT2 inhibitors and GLP‑1 receptor agonists is increasingly discussed in the context of cardiovascular risk management in diabetes and is associated with reductions in major a
- Diabetes ‘Much More Dangerous for Men Than Women’https://reachmd.com/news/diabetes-much-more-dangerous-for-men-than-women/2463100/Diabetes is much more dangerous for men than for women, a study has suggested.Researchers found that the rates of heart disease, complications involving the leg, foot and kidneys, and
- Metformin Linked to Lower 5-Year Intermediate AMD Incidence in Diabeteshttps://reachmd.com/news/metformin-linked-to-lower-5-year-intermediate-amd-incidence-in-diabetes/2485584/A population-based 5-year case-control analysis nested within a diabetic retinopathy screening program linked to general-practice prescribing records found that metformin exposure was associated with lower odds of incident intermediate AMD graded directly from images. <
- Balancing Diabetes Management: GLP-1 Receptor Agonists and Yogurt Interventionhttps://reachmd.com/news/balancing-diabetes-management-glp-1-receptor-agonists-and-yogurt-intervention/2483141/In diabetes management's evolving landscape, GLP-1 receptor agonists and dietary interventions like yogurt are redefining treatment paradigms, presenting both opportunities for advancement and challenges to overcome. These innovations offer fresh avenues for patient care, yet invite scrutin
- Enhancing Follow-Up Care in Diabetic Eye Disease: Challenges and Innovationshttps://reachmd.com/news/enhancing-follow-up-care-in-diabetic-eye-disease-challenges-and-innovations/2476102/In diabetic eye disease, the stakes involve maintaining not just patient sight, but also their quality of life—a balancing act complicated by inconsistent follow-up. Ensuring clinical follow-up as recommended by the American Academy of Ophthalmology remains a recurring challenge, dee
- Innovations in Diabetes Technology and the Socioeconomic Challenge: Striving for Equity in Carehttps://reachmd.com/news/innovations-in-diabetes-technology-and-the-socioeconomic-challenge-striving-for-equity-in-care/2476127/The rapid transformation of diabetes management technologies is presenting a dual-edged narrative. While innovations like continuous glucose monitoring and advanced insulin delivery systems are promising a new era of care, they are also illuminating stark inequities rooted in socioe
- Transforming Diabetes Care: Integrating GLP-1 Agonists with Adjunct Therapieshttps://reachmd.com/news/transforming-diabetes-care-integrating-glp-1-agonists-with-adjunct-therapies/2476019/As diabetes-related complications surge, clinicians are turning to adjunct therapies to rescue patients from the limits of standard insulin regimens; integrating GLP-1 receptor agonists markedly enhances glycemic control, reduces insulin requirements, and supports weight management as demon